FDA detects diversion of cough syrup to Bangladesh
The Haryana food and drug administration (FDA) has unearthed a racket of illicit diversion and transportation of codeine cough preparation manufactured and sold by multinational pharmaceutical giant Abbott Laboratories Ltd.Updated: Mar 02, 2014 19:52 IST
The Haryana food and drug administration (FDA) has unearthed a racket of illicit diversion and transportation of codeine cough preparation manufactured and sold by multinational pharmaceutical giant Abbott Laboratories Ltd.
An FDA spokesperson said more than 2 lakh bottles of popular cough syrup, Phensedyl Cough Linctus, worth more than Rs 1 crore, which were allegedly supplied by the manufacturing company to a Hisar-based wholesaler firm JP Medicose were found to have been diverted to Bangladesh illegally in connivance with another non-functional Bhiwani-based medicine wholesaler.
The spokesperson said investigations by the FDA officers revealed that the huge quantities of this cough syrup were supplied by the company directly to the Hisar dealer, who had further shown to have supplied the entire stocks to a Bhiwani-based unlicenced medicine trader.
The entire sales were found to have been made to this Bhiwani-based firm without any supply order and shown to have been made against cash payment, he said.
He further said on further investigations it was found that the entire sale was fake as the firm to whom sales have been made was non-existent. A first-information report (FIR) was registered under various provisions of the Narcotic Drugs and Psychotropic Substances (NDPS) Act against the Hisar-based firm and its owner at Hisar police station for illicit shipment of more than 40-kg codeine.
The illicit shipment of the medicine was also under investigation by directorate of revenue intelligence (DRI), West Bengal. The licenced premises of the firm have also been sealed by the department.
The FDA spokesperson said investigations in the case led to the surfacing of another supply of 1.5 lakh bottles of this cough syrup by the multinational company to another Ambala-based medicine trader, Laxmi Drugs Store, Nicholson Road, Ambala, who also siphoned off the entire stocks illicitly and prepared fake documents to have sold the drug to a wholesaler who never purchased even a single bottle of this product.
The department has also registered an FIR against this firm and its owner under the NDPS Act and the IPC and has sealed its licenced premises. The cases are further investigated by the FDA officers to expose and nab the others involved in the crime.